img

Global Botanical and Plant Derivative Drug Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Botanical and Plant Derivative Drug Market Research Report 2024

A botanical drug product is intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in humans.
According to Mr Accuracy reports new survey, global Botanical and Plant Derivative Drug market is projected to reach US$ 50560 million in 2029, increasing from US$ 36500 million in 2022, with the CAGR of 4.8% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Botanical and Plant Derivative Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Botanical and Plant Derivative Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica Se
Huarun 999
Taiji
Weleda
Kwangdong
GW Pharmaceuticals
Segment by Type
Prescription Drug
OTC

Segment by Application


Cardiovascular
Tumor
Respiratory System
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Botanical and Plant Derivative Drug report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Botanical and Plant Derivative Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Prescription Drug
1.2.3 OTC
1.3 Market by Application
1.3.1 Global Botanical and Plant Derivative Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cardiovascular
1.3.3 Tumor
1.3.4 Respiratory System
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Botanical and Plant Derivative Drug Market Perspective (2018-2029)
2.2 Botanical and Plant Derivative Drug Growth Trends by Region
2.2.1 Global Botanical and Plant Derivative Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Botanical and Plant Derivative Drug Historic Market Size by Region (2018-2024)
2.2.3 Botanical and Plant Derivative Drug Forecasted Market Size by Region (2024-2029)
2.3 Botanical and Plant Derivative Drug Market Dynamics
2.3.1 Botanical and Plant Derivative Drug Industry Trends
2.3.2 Botanical and Plant Derivative Drug Market Drivers
2.3.3 Botanical and Plant Derivative Drug Market Challenges
2.3.4 Botanical and Plant Derivative Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Botanical and Plant Derivative Drug Players by Revenue
3.1.1 Global Top Botanical and Plant Derivative Drug Players by Revenue (2018-2024)
3.1.2 Global Botanical and Plant Derivative Drug Revenue Market Share by Players (2018-2024)
3.2 Global Botanical and Plant Derivative Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Botanical and Plant Derivative Drug Revenue
3.4 Global Botanical and Plant Derivative Drug Market Concentration Ratio
3.4.1 Global Botanical and Plant Derivative Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Botanical and Plant Derivative Drug Revenue in 2022
3.5 Botanical and Plant Derivative Drug Key Players Head office and Area Served
3.6 Key Players Botanical and Plant Derivative Drug Product Solution and Service
3.7 Date of Enter into Botanical and Plant Derivative Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Botanical and Plant Derivative Drug Breakdown Data by Type
4.1 Global Botanical and Plant Derivative Drug Historic Market Size by Type (2018-2024)
4.2 Global Botanical and Plant Derivative Drug Forecasted Market Size by Type (2024-2029)
5 Botanical and Plant Derivative Drug Breakdown Data by Application
5.1 Global Botanical and Plant Derivative Drug Historic Market Size by Application (2018-2024)
5.2 Global Botanical and Plant Derivative Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Botanical and Plant Derivative Drug Market Size (2018-2029)
6.2 North America Botanical and Plant Derivative Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Botanical and Plant Derivative Drug Market Size by Country (2018-2024)
6.4 North America Botanical and Plant Derivative Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Botanical and Plant Derivative Drug Market Size (2018-2029)
7.2 Europe Botanical and Plant Derivative Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Botanical and Plant Derivative Drug Market Size by Country (2018-2024)
7.4 Europe Botanical and Plant Derivative Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Botanical and Plant Derivative Drug Market Size (2018-2029)
8.2 Asia-Pacific Botanical and Plant Derivative Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Botanical and Plant Derivative Drug Market Size by Region (2018-2024)
8.4 Asia-Pacific Botanical and Plant Derivative Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Botanical and Plant Derivative Drug Market Size (2018-2029)
9.2 Latin America Botanical and Plant Derivative Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Botanical and Plant Derivative Drug Market Size by Country (2018-2024)
9.4 Latin America Botanical and Plant Derivative Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Botanical and Plant Derivative Drug Market Size (2018-2029)
10.2 Middle East & Africa Botanical and Plant Derivative Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Botanical and Plant Derivative Drug Market Size by Country (2018-2024)
10.4 Middle East & Africa Botanical and Plant Derivative Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Buchang Pharmaceuticals
11.1.1 Buchang Pharmaceuticals Company Detail
11.1.2 Buchang Pharmaceuticals Business Overview
11.1.3 Buchang Pharmaceuticals Botanical and Plant Derivative Drug Introduction
11.1.4 Buchang Pharmaceuticals Revenue in Botanical and Plant Derivative Drug Business (2018-2024)
11.1.5 Buchang Pharmaceuticals Recent Development
11.2 China TCM
11.2.1 China TCM Company Detail
11.2.2 China TCM Business Overview
11.2.3 China TCM Botanical and Plant Derivative Drug Introduction
11.2.4 China TCM Revenue in Botanical and Plant Derivative Drug Business (2018-2024)
11.2.5 China TCM Recent Development
11.3 Tsumura
11.3.1 Tsumura Company Detail
11.3.2 Tsumura Business Overview
11.3.3 Tsumura Botanical and Plant Derivative Drug Introduction
11.3.4 Tsumura Revenue in Botanical and Plant Derivative Drug Business (2018-2024)
11.3.5 Tsumura Recent Development
11.4 Schwabe
11.4.1 Schwabe Company Detail
11.4.2 Schwabe Business Overview
11.4.3 Schwabe Botanical and Plant Derivative Drug Introduction
11.4.4 Schwabe Revenue in Botanical and Plant Derivative Drug Business (2018-2024)
11.4.5 Schwabe Recent Development
11.5 Tong Ren Tang
11.5.1 Tong Ren Tang Company Detail
11.5.2 Tong Ren Tang Business Overview
11.5.3 Tong Ren Tang Botanical and Plant Derivative Drug Introduction
11.5.4 Tong Ren Tang Revenue in Botanical and Plant Derivative Drug Business (2018-2024)
11.5.5 Tong Ren Tang Recent Development
11.6 Jumpcan Pharmaceutical
11.6.1 Jumpcan Pharmaceutical Company Detail
11.6.2 Jumpcan Pharmaceutical Business Overview
11.6.3 Jumpcan Pharmaceutical Botanical and Plant Derivative Drug Introduction
11.6.4 Jumpcan Pharmaceutical Revenue in Botanical and Plant Derivative Drug Business (2018-2024)
11.6.5 Jumpcan Pharmaceutical Recent Development
11.7 Guangzhou Baiyunshan Pharmaceutical
11.7.1 Guangzhou Baiyunshan Pharmaceutical Company Detail
11.7.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
11.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical and Plant Derivative Drug Introduction
11.7.4 Guangzhou Baiyunshan Pharmaceutical Revenue in Botanical and Plant Derivative Drug Business (2018-2024)
11.7.5 Guangzhou Baiyunshan Pharmaceutical Recent Development
11.8 Yunnan Baiyao
11.8.1 Yunnan Baiyao Company Detail
11.8.2 Yunnan Baiyao Business Overview
11.8.3 Yunnan Baiyao Botanical and Plant Derivative Drug Introduction
11.8.4 Yunnan Baiyao Revenue in Botanical and Plant Derivative Drug Business (2018-2024)
11.8.5 Yunnan Baiyao Recent Development
11.9 Tasly Holding Group
11.9.1 Tasly Holding Group Company Detail
11.9.2 Tasly Holding Group Business Overview
11.9.3 Tasly Holding Group Botanical and Plant Derivative Drug Introduction
11.9.4 Tasly Holding Group Revenue in Botanical and Plant Derivative Drug Business (2018-2024)
11.9.5 Tasly Holding Group Recent Development
11.10 Bionorica Se
11.10.1 Bionorica Se Company Detail
11.10.2 Bionorica Se Business Overview
11.10.3 Bionorica Se Botanical and Plant Derivative Drug Introduction
11.10.4 Bionorica Se Revenue in Botanical and Plant Derivative Drug Business (2018-2024)
11.10.5 Bionorica Se Recent Development
11.11 Huarun 999
11.11.1 Huarun 999 Company Detail
11.11.2 Huarun 999 Business Overview
11.11.3 Huarun 999 Botanical and Plant Derivative Drug Introduction
11.11.4 Huarun 999 Revenue in Botanical and Plant Derivative Drug Business (2018-2024)
11.11.5 Huarun 999 Recent Development
11.12 Taiji
11.12.1 Taiji Company Detail
11.12.2 Taiji Business Overview
11.12.3 Taiji Botanical and Plant Derivative Drug Introduction
11.12.4 Taiji Revenue in Botanical and Plant Derivative Drug Business (2018-2024)
11.12.5 Taiji Recent Development
11.13 Weleda
11.13.1 Weleda Company Detail
11.13.2 Weleda Business Overview
11.13.3 Weleda Botanical and Plant Derivative Drug Introduction
11.13.4 Weleda Revenue in Botanical and Plant Derivative Drug Business (2018-2024)
11.13.5 Weleda Recent Development
11.14 Kwangdong
11.14.1 Kwangdong Company Detail
11.14.2 Kwangdong Business Overview
11.14.3 Kwangdong Botanical and Plant Derivative Drug Introduction
11.14.4 Kwangdong Revenue in Botanical and Plant Derivative Drug Business (2018-2024)
11.14.5 Kwangdong Recent Development
11.15 GW Pharmaceuticals
11.15.1 GW Pharmaceuticals Company Detail
11.15.2 GW Pharmaceuticals Business Overview
11.15.3 GW Pharmaceuticals Botanical and Plant Derivative Drug Introduction
11.15.4 GW Pharmaceuticals Revenue in Botanical and Plant Derivative Drug Business (2018-2024)
11.15.5 GW Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Botanical and Plant Derivative Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Prescription Drug
Table 3. Key Players of OTC
Table 4. Global Botanical and Plant Derivative Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Botanical and Plant Derivative Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Botanical and Plant Derivative Drug Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Botanical and Plant Derivative Drug Market Share by Region (2018-2024)
Table 8. Global Botanical and Plant Derivative Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Botanical and Plant Derivative Drug Market Share by Region (2024-2029)
Table 10. Botanical and Plant Derivative Drug Market Trends
Table 11. Botanical and Plant Derivative Drug Market Drivers
Table 12. Botanical and Plant Derivative Drug Market Challenges
Table 13. Botanical and Plant Derivative Drug Market Restraints
Table 14. Global Botanical and Plant Derivative Drug Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Botanical and Plant Derivative Drug Market Share by Players (2018-2024)
Table 16. Global Top Botanical and Plant Derivative Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Botanical and Plant Derivative Drug as of 2022)
Table 17. Ranking of Global Top Botanical and Plant Derivative Drug Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Botanical and Plant Derivative Drug Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Botanical and Plant Derivative Drug Product Solution and Service
Table 21. Date of Enter into Botanical and Plant Derivative Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Botanical and Plant Derivative Drug Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Botanical and Plant Derivative Drug Revenue Market Share by Type (2018-2024)
Table 25. Global Botanical and Plant Derivative Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Botanical and Plant Derivative Drug Revenue Market Share by Type (2024-2029)
Table 27. Global Botanical and Plant Derivative Drug Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Botanical and Plant Derivative Drug Revenue Market Share by Application (2018-2024)
Table 29. Global Botanical and Plant Derivative Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Botanical and Plant Derivative Drug Revenue Market Share by Application (2024-2029)
Table 31. North America Botanical and Plant Derivative Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Botanical and Plant Derivative Drug Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Botanical and Plant Derivative Drug Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Botanical and Plant Derivative Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Botanical and Plant Derivative Drug Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Botanical and Plant Derivative Drug Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Botanical and Plant Derivative Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Botanical and Plant Derivative Drug Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Botanical and Plant Derivative Drug Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Botanical and Plant Derivative Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Botanical and Plant Derivative Drug Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Botanical and Plant Derivative Drug Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Botanical and Plant Derivative Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Botanical and Plant Derivative Drug Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Botanical and Plant Derivative Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. Buchang Pharmaceuticals Company Detail
Table 47. Buchang Pharmaceuticals Business Overview
Table 48. Buchang Pharmaceuticals Botanical and Plant Derivative Drug Product
Table 49. Buchang Pharmaceuticals Revenue in Botanical and Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 50. Buchang Pharmaceuticals Recent Development
Table 51. China TCM Company Detail
Table 52. China TCM Business Overview
Table 53. China TCM Botanical and Plant Derivative Drug Product
Table 54. China TCM Revenue in Botanical and Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 55. China TCM Recent Development
Table 56. Tsumura Company Detail
Table 57. Tsumura Business Overview
Table 58. Tsumura Botanical and Plant Derivative Drug Product
Table 59. Tsumura Revenue in Botanical and Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 60. Tsumura Recent Development
Table 61. Schwabe Company Detail
Table 62. Schwabe Business Overview
Table 63. Schwabe Botanical and Plant Derivative Drug Product
Table 64. Schwabe Revenue in Botanical and Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 65. Schwabe Recent Development
Table 66. Tong Ren Tang Company Detail
Table 67. Tong Ren Tang Business Overview
Table 68. Tong Ren Tang Botanical and Plant Derivative Drug Product
Table 69. Tong Ren Tang Revenue in Botanical and Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 70. Tong Ren Tang Recent Development
Table 71. Jumpcan Pharmaceutical Company Detail
Table 72. Jumpcan Pharmaceutical Business Overview
Table 73. Jumpcan Pharmaceutical Botanical and Plant Derivative Drug Product
Table 74. Jumpcan Pharmaceutical Revenue in Botanical and Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 75. Jumpcan Pharmaceutical Recent Development
Table 76. Guangzhou Baiyunshan Pharmaceutical Company Detail
Table 77. Guangzhou Baiyunshan Pharmaceutical Business Overview
Table 78. Guangzhou Baiyunshan Pharmaceutical Botanical and Plant Derivative Drug Product
Table 79. Guangzhou Baiyunshan Pharmaceutical Revenue in Botanical and Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 80. Guangzhou Baiyunshan Pharmaceutical Recent Development
Table 81. Yunnan Baiyao Company Detail
Table 82. Yunnan Baiyao Business Overview
Table 83. Yunnan Baiyao Botanical and Plant Derivative Drug Product
Table 84. Yunnan Baiyao Revenue in Botanical and Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 85. Yunnan Baiyao Recent Development
Table 86. Tasly Holding Group Company Detail
Table 87. Tasly Holding Group Business Overview
Table 88. Tasly Holding Group Botanical and Plant Derivative Drug Product
Table 89. Tasly Holding Group Revenue in Botanical and Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 90. Tasly Holding Group Recent Development
Table 91. Bionorica Se Company Detail
Table 92. Bionorica Se Business Overview
Table 93. Bionorica Se Botanical and Plant Derivative Drug Product
Table 94. Bionorica Se Revenue in Botanical and Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 95. Bionorica Se Recent Development
Table 96. Huarun 999 Company Detail
Table 97. Huarun 999 Business Overview
Table 98. Huarun 999 Botanical and Plant Derivative Drug Product
Table 99. Huarun 999 Revenue in Botanical and Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 100. Huarun 999 Recent Development
Table 101. Taiji Company Detail
Table 102. Taiji Business Overview
Table 103. Taiji Botanical and Plant Derivative Drug Product
Table 104. Taiji Revenue in Botanical and Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 105. Taiji Recent Development
Table 106. Weleda Company Detail
Table 107. Weleda Business Overview
Table 108. Weleda Botanical and Plant Derivative Drug Product
Table 109. Weleda Revenue in Botanical and Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 110. Weleda Recent Development
Table 111. Kwangdong Company Detail
Table 112. Kwangdong Business Overview
Table 113. Kwangdong Botanical and Plant Derivative Drug Product
Table 114. Kwangdong Revenue in Botanical and Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 115. Kwangdong Recent Development
Table 116. GW Pharmaceuticals Company Detail
Table 117. GW Pharmaceuticals Business Overview
Table 118. GW Pharmaceuticals Botanical and Plant Derivative Drug Product
Table 119. GW Pharmaceuticals Revenue in Botanical and Plant Derivative Drug Business (2018-2024) & (US$ Million)
Table 120. GW Pharmaceuticals Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Botanical and Plant Derivative Drug Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Botanical and Plant Derivative Drug Market Share by Type: 2022 VS 2029
Figure 3. Prescription Drug Features
Figure 4. OTC Features
Figure 5. Global Botanical and Plant Derivative Drug Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 6. Global Botanical and Plant Derivative Drug Market Share by Application: 2022 VS 2029
Figure 7. Cardiovascular Case Studies
Figure 8. Tumor Case Studies
Figure 9. Respiratory System Case Studies
Figure 10. Other Case Studies
Figure 11. Botanical and Plant Derivative Drug Report Years Considered
Figure 12. Global Botanical and Plant Derivative Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Botanical and Plant Derivative Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Botanical and Plant Derivative Drug Market Share by Region: 2022 VS 2029
Figure 15. Global Botanical and Plant Derivative Drug Market Share by Players in 2022
Figure 16. Global Top Botanical and Plant Derivative Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Botanical and Plant Derivative Drug as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Botanical and Plant Derivative Drug Revenue in 2022
Figure 18. North America Botanical and Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Botanical and Plant Derivative Drug Market Share by Country (2018-2029)
Figure 20. United States Botanical and Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Botanical and Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Botanical and Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Botanical and Plant Derivative Drug Market Share by Country (2018-2029)
Figure 24. Germany Botanical and Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Botanical and Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Botanical and Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Botanical and Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Botanical and Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Botanical and Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Botanical and Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Botanical and Plant Derivative Drug Market Share by Region (2018-2029)
Figure 32. China Botanical and Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Botanical and Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Botanical and Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Botanical and Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Botanical and Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Botanical and Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Botanical and Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Botanical and Plant Derivative Drug Market Share by Country (2018-2029)
Figure 40. Mexico Botanical and Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Botanical and Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Botanical and Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Botanical and Plant Derivative Drug Market Share by Country (2018-2029)
Figure 44. Turkey Botanical and Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Botanical and Plant Derivative Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Buchang Pharmaceuticals Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2018-2024)
Figure 47. China TCM Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2018-2024)
Figure 48. Tsumura Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2018-2024)
Figure 49. Schwabe Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2018-2024)
Figure 50. Tong Ren Tang Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2018-2024)
Figure 51. Jumpcan Pharmaceutical Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2018-2024)
Figure 52. Guangzhou Baiyunshan Pharmaceutical Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2018-2024)
Figure 53. Yunnan Baiyao Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2018-2024)
Figure 54. Tasly Holding Group Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2018-2024)
Figure 55. Bionorica Se Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2018-2024)
Figure 56. Huarun 999 Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2018-2024)
Figure 57. Taiji Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2018-2024)
Figure 58. Weleda Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2018-2024)
Figure 59. Kwangdong Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2018-2024)
Figure 60. GW Pharmaceuticals Revenue Growth Rate in Botanical and Plant Derivative Drug Business (2018-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed